This article is more than 5 years old. Information may no longer be current.
Healio.com to provide live coverage from AHA 2015
Click Here to Manage Email Alerts
The Cardiology Today, Cardiology Today’s Intervention and Healio.com/Cardiology team will provide live coverage from the American Heart Association Scientific Sessions, beginning Sunday, Nov. 8.
Late-breaking clinical trials
This year’s conference will feature six sessions devoted to late-breaking clinical trials, including two individual sessions focusing on data from the SPRINT trial and 2-year results from the CT Surgery Network Severe MR trial. Topics addressed during the late-breaking sessions will include new treatments and systems of care, advancements in CVD prevention and PCI for patients with ACS.
Other highlights from the late-breaking clinical trial sessions include:
- SOCRATES-REDUCED, which evaluated vericiguat (Bayer, Merck), an oral soluble guanylate cyclase stimulator, in patients with chronic HF and reduced ejection fraction.
- An assessment of remote patient management following discharge for HF.
- An analysis of the effects of a peer-group-based lifestyle intervention on CV risk factors.
- A study on the effect of empagliflozin (Jardiance; Boehringer Ingelheim) on CV outcomes among high-risk patients with diabetes.
- Long-term results from PEGASUS TIMI-54 on the tolerability of ticagrelor (Brilinta, AstraZeneca).
- 1-year data from AUGMENT-HF, which assessed the efficacy of left ventricular augmentation via an alginate hydrogel in patients with advanced HF.
- BEAT-HF, a first-in-man trial of a β3-adrenoceptor agonist for patients with chronic HF.
- ANNEXA-R Part 2, which evaluated andexanet alfa (AnXa, Portola Pharmaceuticals) as a method of anticoagulation reversal in an older population.
Other highlights
Mark A. Creager
This year, the conference will also include three Clinical Science: Special Reports sessions addressing observations from next-generation registries, new technologies in the field of electrophysiology, and clinical trial updates on the management of CAD risk factors.
Notable lectures this year will be the presidential address, “The Crisis of Vascular Disease and the Journey to Vascular Health,” by Mark A. Creager, MD, FAHA; the Paul Dudley White International Lecture, “Identification of the Vulnerable Plaque: From Bench to Bedside,” by Keith A. Fox, BSC, MB, ChB, FESC, FRCP; and a lecture by Christine Seidman, MD, FAHA, on the genetics of heart disease.
Robert Califf
Other key sessions include an Institute of Medicine report on cardiac arrest, scheduled for presentation on Saturday by Victor Dzau, MD, and a discussion of the influence of the Affordable Care Act on patients, clinicians and scientists by Robert Califf, MD, recently nominated by President Barack Obama to be the next commissioner of the FDA.
Our team will report from Orlando throughout the Scientific Sessions, which will conclude on Nov. 11. Visit Healio.com/Cardiology during the conference and beyond for breaking news, video perspectives from experts in the field on major trial results, and more. Follow our live updates on Twitter at @CardiologyToday.